Breaking News

Actavis Appoints Chief Accounting Officer

August 16, 2013

D'Arecca brings extensive industry experience

James D'Arecca has been appointed chief accounting officer at Actavis, Inc. He reports to R. Todd Joyce, global chief financial officer. Mr. D'Arecca joins the company from Bausch & Lomb, where he served in a similar role to his new position at Actavis.
 
Prior to Bausch & Lomb, he served as executive director and business development controller at Merck, where he was the primary liaison between the controller's organization and the business development and corporate licensing functions. Previously, Mr. D'Arecca was executive director and assistant controller at Schering-Plough. He also spent 13 years with PricewaterhouseCoopers, with a focus on pharmaceuticals, medical devices and consumer products.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks